- $642.01m
- $977.28m
- $375.05m
- 63
- 93
- 46
- 75
2019 December 31st | 2020 December 31st | 2021 September 30th | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.91 | 3.04 | 151 | 322 | 375 |
Cost of Revenue | |||||
Gross Profit | 1.53 | -0.053 | 120 | 270 | 291 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.42 | 6.69 | 91.2 | 118 | 203 |
Operating Profit | -0.505 | -3.65 | 59.9 | 204 | 172 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.464 | -3.65 | -33.9 | 151 | 146 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.436 | -3.65 | -46.9 | 118 | 112 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.436 | -3.65 | -65.7 | 118 | 112 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.436 | -3.65 | -67.2 | 118 | 112 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.524 | -3.27 | -2.87 | 6.39 | 6.17 |
Dividends per Share |